The AJMC® Lung Cancer compendium is a comprehensive resource for clinical news and expert insights for the condition.
The American Cancer Society expanded eligibility for lung cancer screening; experts advised patients to do their research before choosing a plan from the Affordable Care Act’s insurance marketplaces; Republican-led states partnering with rideshare companies for medical appointment rides.
Read More
Adding Adjuvant Nivolumab Builds on Standard of Care for Resectable NSCLC
October 22nd 2023The results of CheckMate 77T showcase the improved event-free survival for patients with resectable non–small cell lung cancer who receive nivolumab in both the neoadjuvant and adjuvant setting and may have practice-changing implications.
Read More
FDA Grants Pembrolizumab Sixth Indication in NSCLC
October 17th 2023The anti–PD-1 agent pembrolizumab was granted a new indication to treat patients with resectable non–small cell lung cancer (NSCLC) as a neoadjuvant treatment with chemotherapy and continued as adjuvant treatment after surgery.
Read More
Takeda to Voluntarily Withdraw Mobocertinib for EGFR Exon 20 Insertion+ NSCLC
October 4th 2023Following discussions with FDA, Takeda will voluntarily withdraw mobocertinib in the United States for adult patients with EGFR exon 20 insertion mutation–positive, locally advanced or metastatic non–small cell lung cancer (NSCLC) based on the outcomes of the phase 3 EXCLAIM-2 trial.
Read More
Patients With NSCLC Describe Experiences of Symptoms on Daily Life
September 12th 2023Patients with advanced or metastatic non–small cell lung cancer (NSCLC) were able to specify a 1-point threshold when describing meaningful symptom change, for better or worse, that helped illustrate their symptom experience.
Read More
Liquid Biopsy Might Be Useful in the Detection of Colorectal, Lung Cancer
September 6th 2023Investigators wanted to analyze the diagnostic performance of methylation-sensitive restriction enzyme digestion followed by sequencing using cell-free DNA and explore the cancer signal origin of the cancer using DNN analyses for colorectal and lung cancers.
Read More
Risk Prediction Improvements Needed for Former Smokers at High Risk for Lung Cancer
July 26th 2023Prediction models are needed to identify individuals at high risk for lung cancer who are former smokers and for whom low-dose computed tomography screening is not recommended, according to one study.
Read More
Standardized SIF Reporting, Management Guidelines Needed in LDCT Lung Screening
July 12th 2023A retrospective case series study suggests that standardized guidelines for reporting and managing significant incidental findings (SIFs) in low-dose computed tomography (LDCT) lung cancer screening could help optimize the treatment of patients whose LDCT scans show SIFs.
Read More